Hikma Pharmaceuticals PLC Share Price and Company Fundamentals



Price
£1532.5
Change
-32.500 (-2.077%)
52 week
1459.5 - 2625.0

Last traded: Last Friday at 4:25 PM

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.

Key Metrics

PE ratio

12.76

PB ratio

1.93

Dividend yield

0.04%

Beta

0.09

Market cap

-

Enterprise value

-

Company profile

Industry / SectorDrug Manufacturers—Specialty & Generic / Healthcare
Full time employees8700
Websitehttps://www.hikma.com
Mailing address1 New Burlington Place London W1S 2HR United Kingdom
Phone / Fax44 20 7399 2760 / 44 20 7399 2761

Dividends

Dividend yield

0.04%

Dividend amount

£0.55

Payout ratio

34.76%

5Y Avg. yield

1.75%

Hikma Pharmaceuticals PLC paid £0.55 dividend and the ex-dividend date was 18 Aug 2022.The dividend payout ratio is 34.76%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.HIK dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

HIK's forward dividend amount is £0.42 and the forward dividend yield is 2.74%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Aug 2022, following are the company executives and directors listed on Hikma Pharmaceuticals PLC.

NameTitleAgeTotal Pay
Engineer Said Samih Taleb DarwazahExec. Chairman & CEO642.71M
Mr. Mazen Samih Taleb DarwazahExec. Vice Chairman & Pres of MENA632.11M
Mr. Khalid Waleed Hosny Al NabilsiChief Financial Officer49
Dr. Shahin FesharakiChief Scientific Officer
Mr. Hussein ArkhaghaCompany Sec. & Chief Counsel
Mr. Bassam Wael Rushdi Kanaan CFA, CPAExec. VP of Corp. Devel. and M&A56
Ms. Susan RingdalExec. VP of Strategic Planning & Global Affairs
Ms. Majda LabadiExec. VP of Organisational Devel.
Mr. Riad MishlawiPres of Injectables
Mr. Brian HoffmannPres of Generics

Profitability and management effectiveness

Profit margin

13.57%

Operating margin

21.57%

Return on assets

7.70%

Return on equity

15.40%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Hikma Pharmaceuticals PLC is and its enterprise value is .

The HIK's stocks Beta value is 0.09 making it 91% less volatile compared to LSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Hikma Pharmaceuticals PLC (LSE:HIK) Frequently Asked Questions

1. What is Hikma Pharmaceuticals PLC's Stock Symbol?

Hikma Pharmaceuticals PLC trades on LSE under the ticker symbol "HIK".

2. What is Hikma Pharmaceuticals PLC's stock price today?

One share of HIK stock can currently be purchased for approximately £1532.5.

3. How can I contact Hikma Pharmaceuticals PLC?

Hikma Pharmaceuticals PLC's mailing address is 1 New Burlington Place London W1S 2HR United Kingdom. The company can be reached via phone at 44 20 7399 2760.

4. What is Hikma Pharmaceuticals PLC's official website?

The official website of Hikma Pharmaceuticals PLC is https://www.hikma.com.